These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 1584353)

  • 21. Protective effect of a 21-aminosteroid on the blood-brain barrier following subarachnoid hemorrhage in rats.
    Zuccarello M; Anderson DK
    Stroke; 1989 Mar; 20(3):367-71. PubMed ID: 2493691
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Breakdown of the blood-brain barrier and neuropathological changes induced by Phoneutria nigriventer spider venom.
    de Paula Le Sueur L; Kalapothakis E; da Cruz-Höfling MA
    Acta Neuropathol; 2003 Feb; 105(2):125-34. PubMed ID: 12536223
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Arachidonic acid increases cerebral microvascular permeability by free radicals in single pial microvessels of the anaesthetized rat.
    Easton AS; Fraser PA
    J Physiol; 1998 Mar; 507 ( Pt 2)(Pt 2):541-7. PubMed ID: 9518711
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Leukotrienes increase blood-brain barrier permeability following intraparenchymal injections in rats.
    Black KL; Hoff JT
    Ann Neurol; 1985 Sep; 18(3):349-51. PubMed ID: 2996417
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mediators of vascular and parenchymal mechanisms in secondary brain damage.
    Wahl M; Schilling L; Unterberg A; Baethmann A
    Acta Neurochir Suppl (Wien); 1993; 57():64-72. PubMed ID: 7678480
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Neuropharmacologic control of cerebral capillary permeability: current implications for therapy of vasogenic brain edema.
    Weinand ME
    Med Hypotheses; 1988 May; 26(1):51-3. PubMed ID: 3398790
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Corticotropin-releasing factor decreases vasogenic brain edema.
    Tjuvajev J; Uehara H; Desai R; Beattie B; Matei C; Zhou Y; Kreek MJ; Koutcher J; Blasberg R
    Cancer Res; 1996 Mar; 56(6):1352-60. PubMed ID: 8640825
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Human malignant gliomas secrete a factor that increases brain capillary permeability: role in peritumoural brain oedema.
    Ohnishi T; Hayakawa T; Shapiro WR
    Acta Neurochir Suppl (Wien); 1990; 51():137-9. PubMed ID: 2089879
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Regulation of permeability across the blood-brain barrier.
    Easton AS
    Adv Exp Med Biol; 2012; 763():1-19. PubMed ID: 23397617
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Amino acids in extracellular fluid in vasogenic brain edema.
    Westergren I; Nyström B; Hamberger A; Johansson BB
    Acta Neurochir Suppl (Wien); 1994; 60():124-7. PubMed ID: 7976523
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Control of vasogenic edema in a brain tumor model: comparison between dexamethasone and superoxide dismutase.
    Shoshan Y; Siegal T
    Neurosurgery; 1996 Dec; 39(6):1206-13; discussion 1213-4. PubMed ID: 8938776
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Blood-brain barrier permeability and vascular reactivity to bradykinin after pretreatment with dexamethasone.
    Schürer L; Temesvari P; Wahl M; Unterberg A; Baethmann A
    Acta Neuropathol; 1989; 77(6):576-81. PubMed ID: 2750477
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Arachidonic acid release from cultured human amnion cells: the effect of dexamethasone.
    Potestio FA; Olson DM
    J Clin Endocrinol Metab; 1990 Mar; 70(3):647-54. PubMed ID: 1689736
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Vascular permeability induced by protein product of malignant brain tumors: inhibition by dexamethasone.
    Bruce JN; Criscuolo GR; Merrill MJ; Moquin RR; Blacklock JB; Oldfield EH
    J Neurosurg; 1987 Dec; 67(6):880-4. PubMed ID: 3681425
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Carrageenan-induced brain inflammation. Characterization of the model.
    Gamache DA; Povlishock JT; Ellis EF
    J Neurosurg; 1986 Nov; 65(5):679-85. PubMed ID: 3772456
    [TBL] [Abstract][Full Text] [Related]  

  • 36. O2 radicals in arachidonate-induced increased blood-brain barrier permeability to proteins.
    Wei EP; Ellison MD; Kontos HA; Povlishock JT
    Am J Physiol; 1986 Oct; 251(4 Pt 2):H693-9. PubMed ID: 3094386
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Neutral proteases and disruption of the blood-brain barrier in rat.
    Armao D; Kornfeld M; Estrada EY; Grossetete M; Rosenberg GA
    Brain Res; 1997 Sep; 767(2):259-64. PubMed ID: 9367256
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Selective opening of the blood-tumor barrier by a nitric oxide donor and long-term survival in rats with C6 gliomas.
    Weyerbrock A; Walbridge S; Pluta RM; Saavedra JE; Keefer LK; Oldfield EH
    J Neurosurg; 2003 Oct; 99(4):728-37. PubMed ID: 14567609
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Repeated, short-term ischemia augments bradykinin-mediated opening of the blood-tumor barrier in rats with RG2 glioma.
    Liu Y; Hashizume K; Samoto K; Sugita M; Ningaraj N; Asotra K; Black KL
    Neurol Res; 2001 Sep; 23(6):631-40. PubMed ID: 11547933
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Intracarotid infusion of leukotriene C4 selectively increases blood-brain barrier permeability after focal ischemia in rats.
    Baba T; Black KL; Ikezaki K; Chen KN; Becker DP
    J Cereb Blood Flow Metab; 1991 Jul; 11(4):638-43. PubMed ID: 1675639
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.